These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 16109110

  • 1. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
    Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, Battikha JP, Hoffman H, Baggish J.
    Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
    [Abstract] [Full Text] [Related]

  • 2. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial--a comment.
    Blumenthal HJ, Diamond ML.
    Headache; 2006 Feb; 46(2):340; author reply 341. PubMed ID: 16492249
    [No Abstract] [Full Text] [Related]

  • 3. A comment on acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
    Wenzel RG.
    Headache; 2006 Feb; 46(2):341; author reply 341-3. PubMed ID: 16492251
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB.
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [Abstract] [Full Text] [Related]

  • 5. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ.
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [Abstract] [Full Text] [Related]

  • 6. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
    Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB.
    Headache; 2006 Mar; 46(3):444-53. PubMed ID: 16618262
    [Abstract] [Full Text] [Related]

  • 7. Acute migraine treatment: patterns of use and satisfaction in a clinical population.
    Malik SN, Hopkins M, Young WB, Silberstein SD.
    Headache; 2006 May; 46(5):773-80. PubMed ID: 16643580
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P, Landy S, Richardson M, Ames M.
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [Abstract] [Full Text] [Related]

  • 11. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
    Friedman BW, Hochberg M, Esses D, Bijur PE, Corbo J, Paternoster J, Solorzano C, Toosi B, Lipton RB, Gallagher EJ.
    Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
    [Abstract] [Full Text] [Related]

  • 12. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P, Rothner AD, Wooten JD, Webster C, Ames M.
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA, Fabbri L, Cavazzuti L.
    Int J Clin Pharmacol Res; 1999 Feb; 19(2):57-64. PubMed ID: 10669900
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 18. Aspirin is efficacious for the treatment of acute migraine.
    Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN.
    Headache; 2005 Apr; 45(4):283-92. PubMed ID: 15836564
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Headache; 2005 Oct; 45(7):874-82. PubMed ID: 15985104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.